Anantha Krishnan Dhanabalan

653 total citations
36 papers, 482 citations indexed

About

Anantha Krishnan Dhanabalan is a scholar working on Computational Theory and Mathematics, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Anantha Krishnan Dhanabalan has authored 36 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Computational Theory and Mathematics, 14 papers in Molecular Biology and 10 papers in Organic Chemistry. Recurrent topics in Anantha Krishnan Dhanabalan's work include Computational Drug Discovery Methods (15 papers), Metal complexes synthesis and properties (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Anantha Krishnan Dhanabalan is often cited by papers focused on Computational Drug Discovery Methods (15 papers), Metal complexes synthesis and properties (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Anantha Krishnan Dhanabalan collaborates with scholars based in India, United States and Japan. Anantha Krishnan Dhanabalan's co-authors include K. Gunasekaran, Jebiti Haribabu, Ramasamy Karvembu, Srividya Swaminathan, Nithya Balakrishnan, Nattamai Bhuvanesh, D. Gayathri, N. Nandhagopal, Mahendiran Dharmasivam and Saranya Sivaraj and has published in prestigious journals such as International Journal of Biological Macromolecules, Dalton Transactions and Journal of Cellular Biochemistry.

In The Last Decade

Anantha Krishnan Dhanabalan

35 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anantha Krishnan Dhanabalan India	14	196	158	133	112	56	36	482
Somsak Ruchirawat Thailand	8	236 1.2×	104 0.7×	149 1.1×	44 0.4×	33 0.6×	21	540
Saman Raza India	10	213 1.1×	85 0.5×	104 0.8×	115 1.0×	36 0.6×	16	395
Jagat Pal Yadav India	13	299 1.5×	74 0.5×	170 1.3×	66 0.6×	45 0.8×	29	650
Zeinab Faghih Iran	17	504 2.6×	177 1.1×	141 1.1×	113 1.0×	53 0.9×	46	667
Muhamad Mustafa Egypt	15	389 2.0×	83 0.5×	277 2.1×	69 0.6×	55 1.0×	37	740
Nahed N. E. El-Sayed Saudi Arabia	17	481 2.5×	58 0.4×	219 1.6×	173 1.5×	74 1.3×	43	802
Carolina D. Duarte France	9	293 1.5×	46 0.3×	177 1.3×	49 0.4×	49 0.9×	11	528
Kapil Juvale India	15	260 1.3×	340 2.2×	312 2.3×	70 0.6×	36 0.6×	37	801
Sumit Tahlan India	15	586 3.0×	65 0.4×	180 1.4×	84 0.8×	54 1.0×	19	746

Countries citing papers authored by Anantha Krishnan Dhanabalan

Since Specialization

Citations

This map shows the geographic impact of Anantha Krishnan Dhanabalan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anantha Krishnan Dhanabalan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anantha Krishnan Dhanabalan more than expected).

Fields of papers citing papers by Anantha Krishnan Dhanabalan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anantha Krishnan Dhanabalan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anantha Krishnan Dhanabalan. The network helps show where Anantha Krishnan Dhanabalan may publish in the future.

Co-authorship network of co-authors of Anantha Krishnan Dhanabalan

This figure shows the co-authorship network connecting the top 25 collaborators of Anantha Krishnan Dhanabalan. A scholar is included among the top collaborators of Anantha Krishnan Dhanabalan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anantha Krishnan Dhanabalan. Anantha Krishnan Dhanabalan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dhanabalan, Anantha Krishnan, et al.. (2025). Chiral 1,3,5‐Triazines as Potential EGFR Inhibitors: Pharmacophore Modeling, Synthesis, Molecular Docking, Molecular Dynamics Simulation, and Anticancer Evaluation. Chemistry & Biodiversity. 22(12). e01632–e01632. 1 indexed citations

Dhanabalan, Anantha Krishnan, et al.. (2024). Identification of potential marine bioactive compounds from brown seaweeds towards BACE1 inhibitors: molecular docking and molecular dynamics simulations approach. In Silico Pharmacology. 12(1). 40–40. 3 indexed citations

Dhanabalan, Anantha Krishnan, et al.. (2024). Identification of a novel drug molecule for neurodegenerative disease from marine algae through in-silico analysis. Journal of Biomolecular Structure and Dynamics. 43(16). 8883–8892. 3 indexed citations

Balakrishnan, Nithya, Jebiti Haribabu, Mahendiran Dharmasivam, et al.. (2023). Influence of Indole-N Substitution of Thiosemicarbazones in Cationic Ru(II)(η⁶-Benzene) Complexes on Their Anticancer Activity. Organometallics. 42(3). 259–275. 20 indexed citations

Dhanabalan, Anantha Krishnan, et al.. (2022). Evaluation of action of steroid molecules on SARS-CoV-2 by inhibiting NSP-15, an endoribonuclease. Molecular Diversity. 27(6). 2715–2728. 2 indexed citations

Dhanabalan, Anantha Krishnan, et al.. (2022). Structure‐based pharmacophore modeling, virtual screening approaches to identifying the potent hepatitis C viral protease and polymerase novel inhibitors. Journal of Cellular Biochemistry. 123(8). 1366–1380. 2 indexed citations

Dhanabalan, Anantha Krishnan, et al.. (2022). Novel derivatives of arabinogalactan, pullulan & lactobionic acid for targeting asialoglycoprotein receptor: Biomolecular interaction, synthesis & evaluation. International Journal of Biological Macromolecules. 207. 683–699. 16 indexed citations

Dhanabalan, Anantha Krishnan, et al.. (2021). Piperazine-substituted derivatives of favipiravir for Nipah virus inhibition: What do in silico studies unravel?. SN Applied Sciences. 3(1). 110–110. 23 indexed citations

Dhanabalan, Anantha Krishnan, et al.. (2021). Understanding the binding mechanism for potential inhibition of SARS‐CoV‐2 Mpro and exploring the modes of ACE2 inhibition by hydroxychloroquine. Journal of Cellular Biochemistry. 123(2). 347–358. 6 indexed citations

10.

Dhanabalan, Anantha Krishnan, et al.. (2021). Identification of a Chlorogenic Ester as a Monoamine Oxidase (MAO-B) Inhibitor by Integrating “Traditional and Machine Learning” Virtual Screening and In Vitro as well as In Vivo Validation: A Lead against Neurodegenerative Disorders?. ACS Chemical Neuroscience. 12(19). 3690–3707. 7 indexed citations

11.

Holy, Chantal E., et al.. (2020). IN3 Impact of Government Measures on COVID-19 Incidence of Reported New Cases: An Analysis of 9 Countries. Value in Health. 23. S403–S403. 1 indexed citations

12.

Nandhagopal, N., et al.. (2020). Isolation and characterization of an iridoid, Arbortristoside-C from Nyctanthes arbor-tristis Linn., a potential drug candidate for diabetes targeting α-glucosidase. Journal of Biomolecular Structure and Dynamics. 40(1). 337–347. 11 indexed citations

13.

Dhanabalan, Anantha Krishnan, et al.. (2020). An interesting paradox of covid-19 illness in chronic lymphocytic leukemia. Indian Journal of Hematology and Blood Transfusion. 36. 1 indexed citations

14.

Balakrishnan, Nithya, Jebiti Haribabu, Anantha Krishnan Dhanabalan, et al.. (2020). Thiosemicarbazone(s)-anchored water soluble mono- and bimetallic Cu(ii) complexes: enzyme-like activities, biomolecular interactions, anticancer property and real-time live cytotoxicity. Dalton Transactions. 49(27). 9411–9424. 61 indexed citations

15.

Dhanabalan, Anantha Krishnan, et al.. (2020). Screening of potential drug for Alzheimer’s disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics. 39(18). 7065–7079. 17 indexed citations

16.

Holy, Chantal E., et al.. (2020). CO3 Effectiveness of Government Measures to Reduce COVID-19 Mortality across 5 Different Countries. Value in Health. 23. S400–S401. 2 indexed citations

17.

Selvakumar, R., Anantha Krishnan Dhanabalan, C. V. Ramakrishnan, Devadasan Velmurugan, & K. Gunasekaran. (2019). Identification of novel NAD(P)H dehydrogenase [quinone] 1 antagonist using computational approaches. Journal of Biomolecular Structure and Dynamics. 38(3). 682–696. 3 indexed citations

18.

Iqbal, Saleem, Anantha Krishnan Dhanabalan, & K. Gunasekaran. (2017). Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer’s disease. Journal of Biomolecular Structure and Dynamics. 36(15). 4029–4044. 20 indexed citations

19.

Haribabu, Jebiti, et al.. (2017). In vitro antioxidant, antiinflammatory and in silico molecular docking studies of thiosemicarbazones. Journal of Molecular Structure. 1145. 160–169. 48 indexed citations

20.

Dhanabalan, Anantha Krishnan, et al.. (2012). Design and development of tractor mounted sugarcane trash shredder.. Madras Agricultural Journal. 99. 901–904. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact